A detailed history of Srs Capital Advisors, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 3,609 shares of NVO stock, worth $315,318. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,609
Previous 3,637 0.77%
Holding current value
$315,318
Previous $519,000 17.34%
% of portfolio
0.04%
Previous 0.05%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$119.07 - $145.42 $3,333 - $4,071
-28 Reduced 0.77%
3,609 $429,000
Q2 2024

Aug 06, 2024

SELL
$122.71 - $146.91 $19,388 - $23,211
-158 Reduced 4.16%
3,637 $519,000
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $18,686 - $24,873
-183 Reduced 4.6%
3,795 $487,000
Q4 2023

Feb 06, 2024

BUY
$87.78 - $105.45 $148,260 - $178,105
1,689 Added 73.79%
3,978 $411,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $111,037 - $243,638
1,221 Added 114.33%
2,289 $208,000
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $1,247 - $1,381
8 Added 0.75%
1,068 $172,000
Q1 2023

May 16, 2023

BUY
$132.34 - $159.14 $12,307 - $14,800
93 Added 9.62%
1,060 $168,000
Q4 2022

Feb 24, 2023

SELL
$102.55 - $135.33 $1,845 - $2,435
-18 Reduced 1.83%
967 $130,000
Q3 2022

Nov 03, 2022

BUY
$95.28 - $116.93 $8,384 - $10,289
88 Added 9.81%
985 $98,000
Q2 2022

Aug 22, 2022

BUY
$103.24 - $121.81 $36,753 - $43,364
356 Added 65.8%
897 $100,000
Q1 2022

May 12, 2022

BUY
$93.1 - $112.54 $46,363 - $56,044
498 Added 1158.14%
541 $60,000
Q4 2021

Feb 08, 2022

BUY
$95.88 - $117.08 $3,355 - $4,097
35 Added 437.5%
43 $5,000
Q3 2021

Nov 05, 2021

BUY
$84.42 - $106.62 $675 - $852
8 New
8 $1,000
Q2 2021

Aug 02, 2021

SELL
$67.66 - $84.76 $7,848 - $9,832
-116 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$63.69 - $70.22 $63 - $70
1 Added 0.87%
116 $8,000
Q2 2020

Aug 06, 2020

BUY
$58.54 - $67.94 $58 - $67
1 Added 0.88%
115 $8,000
Q2 2019

Aug 08, 2019

BUY
$46.79 - $52.47 $93 - $104
2 Added 1.79%
114 $6,000
Q4 2018

Feb 06, 2019

SELL
$41.54 - $47.25 $3,198 - $3,638
-77 Reduced 40.74%
112 $5,000
Q3 2018

Nov 06, 2018

SELL
$46.76 - $51.24 $54,428 - $59,643
-1,164 Reduced 86.03%
189 $9,000
Q2 2018

Aug 21, 2018

SELL
$44.29 - $50.42 $1,948 - $2,218
-44 Reduced 3.15%
1,353 $62,000
Q1 2018

May 14, 2018

SELL
$48.49 - $58.14 $176,988 - $212,211
-3,650 Reduced 72.32%
1,397 $68,000
Q4 2017

Feb 15, 2018

BUY
$47.53 - $53.73 $950 - $1,074
20 Added 0.4%
5,047 $270,000
Q3 2017

Nov 15, 2017

BUY
$41.15 - $49.22 $206,861 - $247,428
5,027
5,027 $242,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Srs Capital Advisors, Inc. Portfolio

Follow Srs Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.